Cargando…

Microglia-Dependent and Independent Brain Cytoprotective Effects of Mycophenolate Mofetil During Neuronal Damage

Acute lesions of the central nervous system often lead to permanent limiting deficits. In addition to the initial primary damage, accompanying neuroinflammation is responsible for progression of damage. Mycophenolate mofetil (MMF) as a selective inhibitor of inosine 5-monophosphate dehydrogenase (IM...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleine, Joshua, Hohmann, Urszula, Hohmann, Tim, Ghadban, Chalid, Schmidt, Miriam, Laabs, Sebastian, Alessandri, Beat, Dehghani, Faramarz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100558/
https://www.ncbi.nlm.nih.gov/pubmed/35572146
http://dx.doi.org/10.3389/fnagi.2022.863598
_version_ 1784706874740834304
author Kleine, Joshua
Hohmann, Urszula
Hohmann, Tim
Ghadban, Chalid
Schmidt, Miriam
Laabs, Sebastian
Alessandri, Beat
Dehghani, Faramarz
author_facet Kleine, Joshua
Hohmann, Urszula
Hohmann, Tim
Ghadban, Chalid
Schmidt, Miriam
Laabs, Sebastian
Alessandri, Beat
Dehghani, Faramarz
author_sort Kleine, Joshua
collection PubMed
description Acute lesions of the central nervous system often lead to permanent limiting deficits. In addition to the initial primary damage, accompanying neuroinflammation is responsible for progression of damage. Mycophenolate mofetil (MMF) as a selective inhibitor of inosine 5-monophosphate dehydrogenase (IMPDH) was shown to modulate the inflammatory response and promote neuronal survival when applied in specific time windows after neuronal injury. The application of brain cytoprotective therapeutics early after neuronal damage is a fundamental requirement for a successful immunomodulation approach. This study was designed to evaluate whether MMF can still mediate brain cytoprotection when applied in predefined short time intervals following CNS injury. Furthermore, the role of microglia and changes in IMPDH2 protein expression were assessed. Organotypic hippocampal slice cultures (OHSC) were used as an in vitro model and excitotoxically lesioned with N-methyl-aspartate (NMDA). Clodronate (Clo) was used to deplete microglia and analyze MMF mediated microglia independent effects. The temporal expression of IMPDH2 was studied in primary glial cell cultures treated with lipopolysaccharide (LPS). In excitotoxically lesioned OHSC a significant brain cytoprotective effect was observed between 8 and 36 h but not within 8 and 24 h after the NMDA damage. MMF mediated effects were mainly microglia dependent at 24, 36, 48 h after injury. However, further targets like astrocytes seem to be involved in protective effects 72 h post-injury. IMPDH2 expression was detected in primary microglia and astrocyte cell cultures. Our data indicate that MMF treatment in OHSC should still be started no later than 8–12 h after injury and should continue at least until 36 h post-injury. Microglia seem to be an essential mediator of the observed brain cytoprotective effects. However, a microglia-independent effect was also found, indicating involvement of astrocytes.
format Online
Article
Text
id pubmed-9100558
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91005582022-05-14 Microglia-Dependent and Independent Brain Cytoprotective Effects of Mycophenolate Mofetil During Neuronal Damage Kleine, Joshua Hohmann, Urszula Hohmann, Tim Ghadban, Chalid Schmidt, Miriam Laabs, Sebastian Alessandri, Beat Dehghani, Faramarz Front Aging Neurosci Neuroscience Acute lesions of the central nervous system often lead to permanent limiting deficits. In addition to the initial primary damage, accompanying neuroinflammation is responsible for progression of damage. Mycophenolate mofetil (MMF) as a selective inhibitor of inosine 5-monophosphate dehydrogenase (IMPDH) was shown to modulate the inflammatory response and promote neuronal survival when applied in specific time windows after neuronal injury. The application of brain cytoprotective therapeutics early after neuronal damage is a fundamental requirement for a successful immunomodulation approach. This study was designed to evaluate whether MMF can still mediate brain cytoprotection when applied in predefined short time intervals following CNS injury. Furthermore, the role of microglia and changes in IMPDH2 protein expression were assessed. Organotypic hippocampal slice cultures (OHSC) were used as an in vitro model and excitotoxically lesioned with N-methyl-aspartate (NMDA). Clodronate (Clo) was used to deplete microglia and analyze MMF mediated microglia independent effects. The temporal expression of IMPDH2 was studied in primary glial cell cultures treated with lipopolysaccharide (LPS). In excitotoxically lesioned OHSC a significant brain cytoprotective effect was observed between 8 and 36 h but not within 8 and 24 h after the NMDA damage. MMF mediated effects were mainly microglia dependent at 24, 36, 48 h after injury. However, further targets like astrocytes seem to be involved in protective effects 72 h post-injury. IMPDH2 expression was detected in primary microglia and astrocyte cell cultures. Our data indicate that MMF treatment in OHSC should still be started no later than 8–12 h after injury and should continue at least until 36 h post-injury. Microglia seem to be an essential mediator of the observed brain cytoprotective effects. However, a microglia-independent effect was also found, indicating involvement of astrocytes. Frontiers Media S.A. 2022-04-29 /pmc/articles/PMC9100558/ /pubmed/35572146 http://dx.doi.org/10.3389/fnagi.2022.863598 Text en Copyright © 2022 Kleine, Hohmann, Hohmann, Ghadban, Schmidt, Laabs, Alessandri and Dehghani. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Kleine, Joshua
Hohmann, Urszula
Hohmann, Tim
Ghadban, Chalid
Schmidt, Miriam
Laabs, Sebastian
Alessandri, Beat
Dehghani, Faramarz
Microglia-Dependent and Independent Brain Cytoprotective Effects of Mycophenolate Mofetil During Neuronal Damage
title Microglia-Dependent and Independent Brain Cytoprotective Effects of Mycophenolate Mofetil During Neuronal Damage
title_full Microglia-Dependent and Independent Brain Cytoprotective Effects of Mycophenolate Mofetil During Neuronal Damage
title_fullStr Microglia-Dependent and Independent Brain Cytoprotective Effects of Mycophenolate Mofetil During Neuronal Damage
title_full_unstemmed Microglia-Dependent and Independent Brain Cytoprotective Effects of Mycophenolate Mofetil During Neuronal Damage
title_short Microglia-Dependent and Independent Brain Cytoprotective Effects of Mycophenolate Mofetil During Neuronal Damage
title_sort microglia-dependent and independent brain cytoprotective effects of mycophenolate mofetil during neuronal damage
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100558/
https://www.ncbi.nlm.nih.gov/pubmed/35572146
http://dx.doi.org/10.3389/fnagi.2022.863598
work_keys_str_mv AT kleinejoshua microgliadependentandindependentbraincytoprotectiveeffectsofmycophenolatemofetilduringneuronaldamage
AT hohmannurszula microgliadependentandindependentbraincytoprotectiveeffectsofmycophenolatemofetilduringneuronaldamage
AT hohmanntim microgliadependentandindependentbraincytoprotectiveeffectsofmycophenolatemofetilduringneuronaldamage
AT ghadbanchalid microgliadependentandindependentbraincytoprotectiveeffectsofmycophenolatemofetilduringneuronaldamage
AT schmidtmiriam microgliadependentandindependentbraincytoprotectiveeffectsofmycophenolatemofetilduringneuronaldamage
AT laabssebastian microgliadependentandindependentbraincytoprotectiveeffectsofmycophenolatemofetilduringneuronaldamage
AT alessandribeat microgliadependentandindependentbraincytoprotectiveeffectsofmycophenolatemofetilduringneuronaldamage
AT dehghanifaramarz microgliadependentandindependentbraincytoprotectiveeffectsofmycophenolatemofetilduringneuronaldamage